Tag: Cellectricon

Uncategorized

New opportunity for discovery of highly differentiated therapeutics for Alzheimer’s & Parkinson’s diseases announced

October 24, 20182 min read

Cellectricon AB, a collaborative research organization dedicated to advancing drug discovery and research in the areas of chronic pain and CNS diseases, today announced the

Alzheimer's disease, Cellectricon, Neuroscience San Diego 2018, Parkingson's disease

You May Have Missed

Business Construction

Base Station RF Power Amplifier Market to Experience Significant Growth Amid 5G Expansion and Rising Mobile Device Adoption

October 24, 2024

Business

World Leaders in Aeronautics, Defence, and Aerospace to Attend the Marrakech Air Show 2024

October 24, 2024

Health & Pharmaceuticals

Sunshine State Dentistry of Boynton Beach Launches New Website to Provide Patients with a Seamless Digital Experience

September 10, 2024

Retail & Services

Metastat Insights Projects Significant Growth in Tattoo Supplies Market by 2031

September 10, 2024September 10, 2024